16JUN

Europe's clade I mpox line goes flat

2 min read

10:26UTC

EU and EEA countries reported 129 clade I mpox cases in June, the first month since ECDC began its dedicated bulletin in which the count held level instead of climbing.

← Back to Bundibugyo's fork stays open Jump to analysis ↓

ScienceAssessed

Key takeaway

Europe's clade I count stopped climbing in June, on a single month of data in a saturating network.

Countries in the EU and the European Economic Area (EEA) reported 129 clade I mpox cases across nine countries in June, and 22 clade II cases across six, ECDC recorded in its week 29 threats report ¹. Clade I is the more severe of the two mpox lineages, the one behind the central African emergency declared in 2024; clade II is the milder lineage responsible for the 2022 global outbreak. June is the first reporting month since ECDC began publishing a dedicated monthly clade I bulletin in which the clade I count held roughly level rather than rising.

The twelve-month totals put the June figure in proportion: 829 clade I cases across 18 countries and 921 clade II cases across 18, with 14% of clade I patients and 8% of clade II patients hospitalised, and two deaths recorded ². Around nine in ten cases in both lineages are in men WHO have sex with men.

That concentration is what makes the plateau ambiguous rather than reassuring. Clade Ib was confirmed circulating locally in Europe last month among patients with no travel history to Africa , so transmission is domestic and no longer purely imported. In a network with dense sexual mixing, incidence flattens when a wave has saturated the contacts it can reach, and it does so whether or not vaccination or behaviour change contributed. A second month at this level would begin to distinguish the two readings. One month does not.

Deep Analysis

In plain English

Mpox, a viral disease related to smallpox, comes in two main types: clade I, which is more severe, and clade II, which is milder. Europe has tracked a rising number of clade I cases for months, but in June the count held steady at 129 cases across nine countries instead of climbing, the first month that has happened since health authorities began a dedicated monthly count.

Deep Analysis

Root Causes

The flat count is the first data point since ECDC identified confirmed local clade Ib transmission among men who have sex with men with no African travel history, the mechanism that justified treating clade I as a distinct European surveillance category rather than an imported-case footnote.

Whether the plateau reflects a genuine transmission slowdown or a reporting lag, cases confirmed in June may still be revised upward as delayed laboratory results arrive, cannot yet be separated from a single month of data.

What could happen next?

Meaning
June is the first month since ECDC's dedicated clade I bulletin began that the case count has not increased, though one month cannot confirm a sustained reversal.
Risk
Monthly case figures are typically provisional and can rise as delayed laboratory confirmations arrive, so June's flat count may not hold.

Sources:ECDC

Mentions:ECDC →mpox →European Union →

First Reported In

Update #11 · Ebola outruns its own contact tracing

ECDC· 21 Jul 2026

Read original →

Causes and effects

Caused by

Europe starts a monthly mpox watch

The monthly clade I bulletin ECDC launched in June is the series in which the flat June count appears.

Occurred 17 Jun 2026

Read story →

Mpox clade Ib now spreads in Europe

Confirmed local clade Ib circulation in Europe is the transmission context the June plateau sits against.

Occurred 12 Jun 2026

Read story →

This Event

Europe's clade I mpox line goes flat

A plateau in a densely connected transmission network usually means the wave has reached the contacts it can reach, which is not the same as importation stopping.

Different Perspectives

Chinese health authorities

China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.

US public health authorities

CIDRAP and Dr Andrew Racine, president of the American Academy of Pediatrics, call 2026's 2,318 confirmed measles cases by 24 July the worst year since 1991's 2,126. Zero deaths against three in 2025 and a 7% hospitalisation rate, down from 11%, show record case counts have not brought record severity.

CEPI

CEPI put an rVSV-platform vaccine candidate specific to Bundibugyo ebolavirus into trial-production on 31 July, developed by Hilleman Laboratories with MSD manufacturing and IAVI's reference virus, funded up to $8.5m. Eleven weeks into the third-largest Ebola outbreak on record, this is the first species-matched candidate; the licensed vaccine covers only Zaire ebolavirus.

Médecins Sans Frontières

MSF reports sexual-violence care in Ituri is almost non-existent, with 7 of 14 health centres closed or relocated by fighting, as Panzi Hospital logs 646 new survivors in six months, an 85% rise. Withdrawn US funding for post-exposure prophylaxis has left clinics across three provinces without PEP kits for months, a crisis running alongside Ebola, not caused by it.

DRC health workers at Elikya Ebola Treatment Centre

Staff at DRC's Elikya Ebola Treatment Centre walked out on 25 July over unpaid wages, the second such action after Rwampara, while unconfirmed suspects occupy up to 64% of the country's isolation beds awaiting lab results. Workers are absorbing a response that has grown faster than its payroll and its labs.

Uganda's Ministry of Health

Uganda's ministry says it discharged its last confirmed patient on 16 June, completed every contact's 21-day follow-up, and declared the country Ebola-free on 28 July, exactly 42 days later. It names Hon. Dr Chris Baryomunsi, Minister of Health, as overseeing a 20-case, 2-death outbreak it now considers closed.